Related Experiment Video
Updated: Jan 28, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme
Olya Stringfield1, John A Arrington2,3, Sandra K Johnston4,5
1IRAT Shared Service.
Abstract:
Standard-of-care multiparameter magnetic resonance imaging (MRI) scans of the brain were used to objectively subdivide glioblastoma multiforme (GBM) tumors into regions that correspond to variations in blood flow, interstitial edema, and cellular density. We hypothesized that the distribution of these distinct tumor ecological "habitats" at the time of presentation will impact the course of the disease. We retrospectively analyzed initial MRI scans in 2 groups of patients diagnosed with GBM, a long-term survival group comprising subjects who survived >36 month postdiagnosis, and a short-term survival group comprising subjects who survived ≤19 month postdiagnosis. The single-institution discovery cohort contained 22 subjects in each group, while the multi-institution validation cohort contained 15 subjects per group. MRI voxel intensities were calibrated, and tumor voxels clustered on contrast-enhanced T1-weighted and fluid-attenuated inversion-recovery (FLAIR) images into 6 distinct "habitats" based on low- to medium- to high-contrast enhancement and low-high signal on FLAIR scans. Habitat 6 (high signal on calibrated contrast-enhanced T1-weighted and FLAIR sequences) comprised a significantly higher volume fraction of tumors in the long-term survival group (discovery cohort, 35% ± 6.5%; validation cohort, 34% ± 4.8%) compared with tumors in the short-term survival group (discovery cohort, 17% ± 4.5%, P < .03; validation cohort, 16 ± 4.0%, P < .007). Of the 6 distinct MRI-defined habitats, the fractional tumor volume of habitat 6 at diagnosis was significantly predictive of long- or short-term survival. We discuss a possible mechanistic basis for this association and implications for habitat-driven adaptive therapy of GBM.
Insights
Glioblastoma multiforme (GBM) tumor habitats identified by MRI predict survival. A specific MRI habitat (Habitat 6) was significantly larger in long-term survivors, suggesting its potential for guiding treatment strategies.
Area of Science:
- Neuro-oncology
- Radiology
- Computational Biology
Background:
- Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
- Standard MRI cannot fully capture tumor heterogeneity, limiting prognostic accuracy.
- Understanding tumor microenvironment variations is crucial for predicting GBM patient outcomes.
Purpose of the Study:
- To investigate if distinct MRI-defined tumor ecological "habitats" at diagnosis correlate with glioblastoma patient survival.
- To identify specific MRI characteristics that can predict long-term versus short-term survival in GBM patients.
Main Methods:
- Retrospective analysis of initial MRI scans from GBM patients categorized into long-term (>36 months) and short-term (≤19 months) survival groups.
- Clustering of tumor voxels into 6 distinct habitats based on contrast enhancement and FLAIR signal intensity.
- Quantitative assessment of the fractional tumor volume for each habitat, particularly Habitat 6.
Main Results:
- A significantly higher volume fraction of Habitat 6 (high signal on contrast-enhanced T1 and FLAIR) was observed in long-term survivors (34-35%) compared to short-term survivors (16-17%) in both discovery and validation cohorts.
- The fractional tumor volume of Habitat 6 at diagnosis was a significant predictor of patient survival outcomes.
- P-values < .03 and < .007 confirmed the statistical significance in both cohorts.
Conclusions:
- MRI-defined tumor habitats, specifically Habitat 6, are significant prognostic biomarkers for glioblastoma.
- The spatial distribution and volume of these habitats at diagnosis can predict patient survival.
- These findings may inform the development of novel, habitat-driven adaptive therapy strategies for GBM.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Related Concept Videos
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Long-term Depression
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Comparing the Survival Analysis of Two or More Groups
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...